The popular heartburn drug, ranitidine, also sold under brand name Zantac, has been discovered to contain dangerous amounts of NDMA, a chemical with a known link to cancer.
One of the primary types of cancer that may be caused by overexposure to NDMA is colorectal cancer, which is a cancer that begins in either the colon or rectum and can spread throughout the body.
The discovery of the NDMA in Zantac was first reported by the U.S. Food and Drug Administration in September 2019. Since the FDA’s initial statement on the issue, more than a dozen Zantac drugmakers have voluntarily recalled their Zantac products, with many stores and pharmacies pulling the drugs off their shelves.
Colorectal cancer is the third most common type of cancer among both men and women in the United States. A confirmed link between Zantac and colorectal cancer could be devastating for thousands of Americans who were unaware of how this drug could increase their risk of developing this life-threatening disease.
If you’ve been diagnosed with colorectal cancer, or lost a loved one to cancer, after taking Zantac long-term for a health condition, you may be eligible to join others in suing the primary manufacturers of Zantac products for compensation.
About Colorectal Cancer
Colorectal cancer, or cancer of the colon or rectum, is one of the most common types of cancer and is also one of the deadliest. Cancer is caused by the DNA mutations in the body that can cause the body to begin producing cells out of control.
According to the American Cancer Society, there are several factors that can increase a person’s risk of developing colorectal cancer. These factors include heavy alcohol use, smoking, older age, and a family history of colorectal cancer.
Common signs and symptoms of colorectal cancer include:
- diarrhea or constipation
- persistent need to have a bowel movement that isn’t relieved by having one
- unintended weight loss
- bright red bleeding from the rectum
- blood in the stool
- stomach cramps and pain
Once diagnosed, the treatment for colorectal cancer largely depends on the type and stage of cancer. Treatment for colorectal cancer may involve local therapies such as surgery, or specialized therapies targeting cells affected by the gene changes.
Zantac And Cancerous Chemical NDMA
Zantac contains the active ingredient, ranitidine, which is known to be effective for treating health conditions such as chronic heartburn, gastric reflux issues, and ulcers. It has commonly been used as a long-term treatment for these conditions, available both over-the-counter and by prescription.
During a round of routine testing of ranitidine products in June 2019, the online pharmacy Valisure detected over three million nanograms (ng) of NDMA in each drug tablet—a number that dangerously exceeds the FDA-recommended safe daily intake of 96 ng.
For decades, agencies such as the World Health Organization (WHO) and U.S. Environmental Protection Agency (EPA) have been aware of the causer-causing effects of being overexposed to NDMA—a chemical formerly used as an ingredient in rocket fuel.
Unlike recent recalls for the blood pressure drug, Valsartan, the NDMA found in Zantac is not an issue of contamination or a manufacturing error.
Multiple studies on ranitidine have found that taking the drug may cause the body to produce excessive amounts of NDMA due to how it breaks down in the body—a dangerous side effect not previously disclosed by the pharmaceutical companies that have produced and profited from Zantac sales.
What’s The Link Between NDMA And Colorectal Cancer?
Symptoms of NDMA overexposure include:
- yellowed skin (jaundice)
- nausea and vomiting
- enlarged liver
- stomach cramps
- reduced liver and kidney function
Not everyone who has taken Zantac is necessarily at risk for developing cancer. According to Harvard Medical School professor, Dr. Joshua Gagne, NDMA is only likely to increase the risk for cancer in people who have taken regular doses of Zantac for an extended amount of time.
The exact risk for developing cancer after using Zantac is still under investigation.
Open lawsuits against Zantac drugmakers have primarily been filed by individuals who developed cancer after taking Zantac for years, or by family members of individuals who took Zantac and later passed away from cancer.
What To Do If You’ve Been Diagnosed With Colorectal Cancer After Taking Zantac
An estimated 15 million people in the United States receive a prescription for Zantac each year for acute and chronic health conditions. This is a staggering number of people who have potentially been exposed to high levels of a cancerous chemical.
Pharmaceutical companies who manufacture drugs like Zantac are responsible for properly informing the government, healthcare providers, and patients of potential side effects and dangers of their drugs. Failing to identify and disclose drug dangers is a violation of federal health and safety laws.
If you or a loved one has been diagnosed with colorectal cancer after regularly taking Zantac, consider taking these steps:
Consult Your Doctor
If you are taking Zantac for a health condition, do not immediately stop taking the drug. Contact your doctor to discuss alternative treatment options that are suitable to meet your medical needs. Many health conditions Zantac treats are treatable through the use of similar drugs that do not contain NDMA.
Contact An Experienced Zantac Lawyer
Thousands of individuals across the U.S. have filed a class action and multidistrict lawsuits against the primary manufacturers of Zantac products for product liability and negligence.
Legal professionals across the country—including Florin|Roebig’s award-winning lawyers—have dedicated themselves to investigating the negligence of Zantac drugmakers and defending the rights of individuals who were unknowingly exposed to the NDMA in Zantac.
No pharmaceutical company is above the law when it comes to protecting the health and safety of consumers. If you suspect you’ve been affected by the NDMA in Zantac, you may be able to seek compensation from Zantac manufacturers to recover money spent on cancer treatment costs, pain and suffering, and Zantac drug expenses.
Our Featured Case Results
Zantac Colorectal Cancer Lawsuits
Colorectal is one of the main types of cancer claimed in Zantac and ranitidine lawsuits. If you or a loved one has developed colorectal cancer after regularly taking Zantac for some time, you may have a case to seek compensation from the primary manufacturers of Zantac products.
Voted one of America’s top law firms, the Zantac lawyers of Florin|Roebig have been closely following the latest information being released about the link between Zantac and cancer.
Our lawyers have a strong record of fighting on behalf of individuals who have been unlawfully harmed by the negligence of powerful companies.
What our award-winning Zantac lawyers can do for you:
- determine your eligibility to file a lawsuit against Zantac drugmakers
- provide an estimated range for how much your case is worth
- consult legal and medical experts to gather support for your case
- provide aggressive legal representation to effectively defend your right to fair compensation
We Are Nationally Awarded Lawyers
Call Today To Schedule A Free Case Evaluation
If you’ve developed colorectal cancer, or lost a loved one to cancer, after taking Zantac, our lawyers want to hear your story. Don’t wait to learn how our lawyers may be able to help you seek justice.
Contact us today to schedule a free case evaluation with our top Zantac lawyers to determine your eligibility to join others in suing negligent Zantac drugmakers.